GlassScriptPhysician profile
Arneyo Perez
NPI 1780662619
$10,456.82
in general payments reported to CMS, 2019-2025
46 companies · $1,210 in 2025
The $1,210 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,701 · 2020: $1,392 · 2021: $2,200 · 2022: $1,119 · 2023: $1,569 · 2024: $1,265 · 2025: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,043.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,124.73 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,501.21 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Allergan, INC. | $1,036.06 | 2019-2022 | |
| Lilly USA, LLC | $782.63 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $544.74 | 2019-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Galderma Laboratories, L.P. | $413.86 | 2019-2023 | |
| Novo Nordisk INC | $387.69 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $326.73 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $269.34 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $263.78 | 2020-2025 | Assurity, Jot Dx, Freestyle Libre 3 |
| Eisai INC. | $251.43 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $251.29 | 2019-2023 | Trintellix |
| Merck Sharp & Dohme LLC | $221.69 | 2019-2025 | Gardasil 9, Capvaxive |
| Nestle Healthcare Nutrition INC. | $182.50 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.78 | 2020-2025 | Jardiance |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arneyo Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.